145020.KQ
Hugel, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 240,500.00
−2.04%Margins
Gross margin
76.3%
EBITDA margin
41.7%
EBIT margin
43.6%
Net margin
32.9%
FCF margin
30.7%
15.0%
Return on equity
13.3%
Return on assets
19.3%
Return on invested capital
0.41x
Asset turnover
KRW 181.4B
Cash from operations
KRW 47.6K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026